Withdrawn applications

  • Email
  • Help

This page allows you to find information on the decision by a pharmaceutical company to withdraw an application made to the European Medicines Agency for a human medicine.

It includes withdrawals of new marketing authorisation applications or for changes to existing marketing authorisations, which are evaluated by the Committee for Medicinal Products for Human Use (CHMP). 

When an application is withdrawn after the first stage of evaluation by the CHMP, a withdrawal assessment report is published. For more information, see:

Document status

Include:

Browse by letter

Search for Withdrawn applications by letter:

Search by keyword

Search for keyword: